Streetbeat News

Earnings

ASM

Avino Silver & Gold Mines (AMEX:ASM) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $0.02. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $0.4689 as of November 6, and are down 32.27% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm

AHCO

AdaptHealth Corp reported Q3 net revenue of $804.0 million, up 6.3% Y/Y, beating consensus estimates. However, the company reported a net loss of $454.1 million due to a $511.9 million pre-tax write-down of goodwill. The company's adjusted EBITDA was $161.2 million, a slight increase from $160.2 million. The company's shares are down 15.21% following the announcement.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 6:53 pm

PRGO

Perrigo Company PLC reported Q3 sales of $1.12 billion, up 2.2% Y/Y, missing the consensus of $1.20 billion. The company reported adjusted EPS of $0.64, beating the consensus of $0.61. However, the company lowered its guidance for net sales growth and revised its FY23 adjusted EPS outlook downwards. Despite this, Perrigo shares are up 5.06% at $29.91 on the last check Tuesday.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 6:41 pm

CVCO

Wedbush analyst Jay McCanless has reiterated an Outperform rating on Cavco Industries, Inc. (NASDAQ:CVCO) but lowered the price target from $390 to $380. This follows a 21.7% decline in Cavco's Q2 FY24 revenue to $452 million and a 17% y/y decline in Q2 shipments. The analyst has also lowered FY24E/FY25E EPS and revenue estimates. However, the analyst raised the average price from $99,000 to $102,000, assuming no widespread pricing pressure from Cavco's competitors.

Portfolio Pulse from Shivani Kumaresan

November 07, 2023 | 6:37 pm

VRTX

Vertex Pharmaceuticals reported Q3 earnings of $4.08 per share, beating estimates of $3.98. However, sales of $2.48 billion missed estimates of $2.50 billion. The company revised its FY23 sales forecast to $9.85 billion. Following the earnings announcement, several analysts adjusted their price targets for Vertex. The company's shares fell 0.6% to $383.51 on Tuesday.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 6:36 pm

BLDP

Ballard Power Systems Inc reported a Q3 FY23 revenue growth of 29% YoY to $127.6 million, beating the consensus of $26.20 million. However, the company reported a gross loss of $(2.8) million and an EPS loss of $(0.21), missing the consensus of $(0.13). The company received ~$14.8 million of new orders in Q3 and delivered orders valued at $27.6 million. The company's cash used in operating activities narrowed to $(22) million, compared to $(30.3) million a year ago. Ballard Power's shares are trading lower by 2.25% at $3.48.

Portfolio Pulse from Akanksha Bakshi

November 07, 2023 | 6:29 pm

ITUB

Itau Unibanco Holding's shares are trading higher following the release of their Q3 earnings report.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:25 pm

BOWL

Bowlero Corp's shares surged by 12% following its Q1 FY24 results. Despite sales and same-store revenue declining, the company reported a net income of $18.2 million, compared to a loss of $33.5 million last year. The company also repurchased 12.1 million shares and reiterated its FY24 revenue outlook. Bowlero plans to reinvest heavily in the business, with significant funds allocated for acquisitions, new builds, and conversions. Last month, the company completed a $432.9 million sale-leaseback transaction.

Portfolio Pulse from Lekha Gupta

November 07, 2023 | 6:21 pm

ROVR

Rover reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates. The company also raised FY23 revenue guidance above estimates and announced an extension of its share repurchase program. This has led to a rise in Rover's share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:18 pm

CLOV

Clover Health's shares are trading lower following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:12 pm